Personal information

Countries

Italy

Activities

Collapse all

Works (10)

EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities

International Journal of Molecular Sciences
2024-11-13 | Journal article
DOI: 10.3390/ijms252212191
Contributors: Lisa Toracchio; Marianna Carrabotta; Caterina Mancarella; Andrea Morrione; Katia Scotlandi
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513757
Contributors: Marianna Carrabotta; Maria Antonella Laginestra; Giorgio Durante; Caterina Mancarella; Lorena Landuzzi; Alessandro Parra; Francesca Ruzzi; Lisa Toracchio; Alessandra De Feo; Veronica Giusti et al.
Source: check_circle
Crossref

Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513757.v1
Contributors: Marianna Carrabotta; Maria Antonella Laginestra; Giorgio Durante; Caterina Mancarella; Lorena Landuzzi; Alessandro Parra; Francesca Ruzzi; Lisa Toracchio; Alessandra De Feo; Veronica Giusti et al.
Source: check_circle
Crossref

Supplementary Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22430962.v1
Contributors: Marianna Carrabotta; Maria Antonella Laginestra; Giorgio Durante; Caterina Mancarella; Lorena Landuzzi; Alessandro Parra; Francesca Ruzzi; Lisa Toracchio; Alessandra De Feo; Veronica Giusti et al.
Source: check_circle
Crossref

Supplementary Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22430965.v1
Contributors: Marianna Carrabotta; Maria Antonella Laginestra; Giorgio Durante; Caterina Mancarella; Lorena Landuzzi; Alessandro Parra; Francesca Ruzzi; Lisa Toracchio; Alessandra De Feo; Veronica Giusti et al.
Source: check_circle
Crossref

Supplementary Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22430962
Contributors: Marianna Carrabotta; Maria Antonella Laginestra; Giorgio Durante; Caterina Mancarella; Lorena Landuzzi; Alessandro Parra; Francesca Ruzzi; Lisa Toracchio; Alessandra De Feo; Veronica Giusti et al.
Source: check_circle
Crossref

Supplementary Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22430965
Contributors: Marianna Carrabotta; Maria Antonella Laginestra; Giorgio Durante; Caterina Mancarella; Lorena Landuzzi; Alessandro Parra; Francesca Ruzzi; Lisa Toracchio; Alessandra De Feo; Veronica Giusti et al.
Source: check_circle
Crossref

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers

Cancers
2022-11-02 | Journal article
DOI: 10.3390/cancers14215411
Contributors: Caterina Mancarella; Marianna Carrabotta; Lisa Toracchio; Katia Scotlandi
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

Cancer Research
2022-02-15 | Journal article
DOI: 10.1158/0008-5472.CAN-21-1222
Contributors: Marianna Carrabotta; Maria Antonella Laginestra; Giorgio Durante; Caterina Mancarella; Lorena Landuzzi; Alessandro Parra; Francesca Ruzzi; Lisa Toracchio; Alessandra De Feo; Veronica Giusti et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy

2018-01-01 | Journal article
DOI: 10.1158/1078-0432.CCR-17-2602
HANDLE: 11585/642720
EID:

2-s2.0-85051210300

PMID: 29703820
WOSUID:

WOS:000440600200024
Source: check_circle
Alma Mater Studiorum Università di Bologna - IRIS
How many people are using ORCID?